Company Overview and News

 
USD180M debt financing positions Bloom Lake Iron Ore Mine for a production restart

2017-07-13 marketwired
Champion Iron Limited (ASX: CIA) (TSX: CIA) ("Champion" or the "Company") is pleased to announce that they secured debt financing conditional commitments of USD180 million for its subsidiary Québec Iron Ore Inc. ("QIO") from la Caisse de dépôt et placement du Québec ("Caisse") and Sprott Resource Lending ("Sprott"). This financing is part of the restart of Bloom Lake Iron Ore Mine's operations, located near Fermont, Québec.
Upvote Downvote

 
Cliffs - This Could Not Be Better

2017-07-12 seekingalpha
Most bonds need to be paid after 2019, which will give the company enough time to prepare.
Upvote Downvote

 
Results of Extraordinary General Meeting Held by Champion Iron Limited on July 10, 2017 in Sydney, NSW, Australia

2017-07-10 marketwired
MONTREAL, QC--(Marketwired - July 10, 2017) - Champion Iron Limited (ASX: CIA) (TSX: CIA) (the "Company", or "Champion") advises that at an Extraordinary General Meeting of the Company's shareholders, which was held in Sydney on July 10, 2017, the following resolutions were passed by the requisite majorities;
Upvote Downvote

 
Champion Iron Subsidiary Quebec Iron Ore Signs Rail Transportation Contract With Quebec North Shore and Labrador Railway Company

2017-06-20 marketwired
MONTREAL, QC--(Marketwired - June 20, 2017) - Champion Iron Limited (ASX: CIA) (TSX: CIA) (the "Company", or "Champion") is pleased to announce that its subsidiary Québec Iron Ore Inc. ("QIO") has entered into a transportation agreement (the "Agreement") with the Quebec North Shore and Labrador Railway Company, Inc. ("QNS&L") for the transportation of iron ore concentrate which would be generated from QIO's Bloom Lake Iron Mine ("Bloom Lake"), located near Fermont, Québec.
Upvote Downvote

 
Champion Iron subsidiary, Quebec Iron Ore Inc., Granted C$5.2 Million in Financial Assistance from Government of Quebec's "Green Fund" for Energy Conversion Projects at its Bloom Lake Mine, Fermont, Quebec

2017-06-06 marketwired
MONTREAL, QC--(Marketwired - June 05, 2017) - Champion Iron Limited (ASX: CIA) (TSX: CIA) ("Champion" or the "Company"), is pleased to announce that its subsidiary Quebec Iron Ore Inc. ("QIO") has been granted C$5.2 million in financial assistance from the Government of Quebec's "Green Fund" in connection with two energy conversion projects at its Bloom Lake Iron Mine ("Bloom Lake"), located near Fermont, Quebec.
Upvote Downvote

 
Champion Iron Completes Sale of $10 Million Convertible Debenture

2017-06-02 marketwired
MONTREAL, QC--(Marketwired - June 01, 2017) - Champion Iron Limited (ASX: CIA) (TSX: CIA) ("Champion" or the "Company"), is pleased to announce that it has completed the previously announced non-brokered sale of a $10 million unsecured subordinated convertible debenture (the "Debenture") to Altius Minerals Corporation ("Altius"). The sale of the Debenture is a component of a CDN$40 million debt and equity bridge financing which Champion arranged for its subsidiary Quebec Iron Ore Inc.
Upvote Downvote

 
Champion Iron subsidiary Quebec Iron Ore Inc. Signs Off-Take Agreement with Sojitz Corporation and Announces $40 Million Bridge Financing in Connection with the Bloom Lake Iron Mine Restart

2017-05-18 marketwired
MONTREAL, QC--(Marketwired - May 18, 2017) - Champion Iron Limited (ASX: CIA) (TSX: CIA) ("Champion" or the "Company"), is pleased to announce that its subsidiary, Quebec Iron Ore Inc. ("QIO"), has signed a Framework Off-Take Agreement (the "Agreement") with Sojitz Corporation ("Sojitz"), a major trading company based in Tokyo, Japan, pursuant to which Sojitz would purchase up to 3,000,000 DMT per annum from QIO after the re-commencement of commercial operations at the Bloom Lake Iron Mine ("Bloom Lake") located near Fermont, Quebec.
Upvote Downvote

 
Champion Iron's subsidiary, Quebec Iron Ore Inc. and the Innu People of Uashat mak Mani-utenam Enter into Impact and Benefits Agreement with respect to the Bloom Lake Mine

2017-04-12 marketwired
MONTREAL, QC--(Marketwired - April 12, 2017) - Champion Iron Limited (ASX: CIA) (TSX: CIA) ("Champion" or the "Company"), through its subsidiary Quebec Iron Ore Inc. ("QIO"), and the band council, Innu of Takuaikan Uashat mak Mani-utenam (ITUM), have entered into an Impact and Benefits Agreement (the "IBA") with respect to future operations at the Bloom Lake Iron Mine ("Bloom Lake") located near Fermont, Quebec.
Upvote Downvote

1
Miners I'm Buying And Why - Part VIII: Sharpshooting Alpha With Junior Mining Plays Of Substance - Small-Cap Stock Observer

2017-04-10 seekingalpha
What's the biggest mistake made by most investors? First, you might recall the performance of specific stocks, which you bought or passed on buying. Then, you might think about the risks versus opportunity costs of being under or over-diversified, or from leveraging with margin, options or futures. Nope, the answer is much simpler, and most investors are guilty of it and don't even realize it.
Upvote Downvote

 
Champion Iron Appoints David Cataford as Chief Operating Officer

2017-03-20 marketwired
Champion Iron Limited (ASX: CIA) (TSX: CIA) ("Champion" or the "Company") is pleased to announce that it has appointed Mr. David Cataford, P. Eng., as Champion's Chief Operating Officer. Mr. Cataford's appointment follows the retirement of Mr. Alexander Horvath, P. Eng., who has agreed to remain as a consultant on an as needed basis. Mr. Cataford first joined Champion in October 2014 as Vice President, Engineering and was instrumental in overseeing the successful completion of the Bloom Lake Mine Feasibility Study, the results of which were recently announced by Champion on February 16, 2017.
Upvote Downvote

 
Champion Iron Files Bloom Lake Mine Feasibility Study

2017-03-18 marketwired
Champion Iron Limited (ASX: CIA) (TSX: CIA) ("Champion" or the "Company") is pleased to announce the filing on SEDAR of the Feasibility Study for the Bloom Lake Iron Ore Mine ("Bloom Lake"), the results of which were previously reported by the Company on February 16, 2017 (the "Release"). Bloom Lake is located near the town of Fermont, in north-eastern Quebec.
Upvote Downvote

 
Champion Iron Acquires 735 Specialized Iron Ore Railcars for Bloom Lake Mine

2017-03-15 marketwired
Champion Iron Limited (ASX: CIA) (TSX: CIA) ("Champion" or the "Company") is pleased to announce that the Bloom Lake Mine ("Bloom Lake") is a step closer to recommencement of mining operations following the acquisition of a fleet of railcars capable of carrying iron ore from its mine near Fermont to the port at Sept-Iles, Québec.
Upvote Downvote

 
Cott Oil and Gas transforming to mineral resource exploration

2017-03-03 proactiveinvestors.com.au
Cott Oil and Gas (ASX:CMT) has entered into an option to acquire up to a 25% interest in Eloro Resources’ (CVE:ELO) La Victoria Gold Silver Project in Peru.
Upvote Downvote

 
Resource Sector Digest: Gold At $1230/oz, What's Next?

2017-02-20 seekingalpha
Germany repatriates its gold from New York and seems to have fallen in love with the shiny stuff.
Upvote Downvote

 
Champion Iron Announces Completion of Bloom Lake Mine Feasibility Study

2017-02-16 marketwired
Champion Iron Limited (ASX: CIA) (TSX: CIA) ("Champion" or the "Company") is pleased to announce the results of the Feasibility Study for the Bloom Lake Iron Ore Mine ("Bloom Lake"), located near the town of Fermont, in north-eastern Quebec.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...